Bio-Rad Laboratories (BIO.B) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free BIO.B Stock Alerts $279.91 -58.64 (-17.32%) (As of 09:13 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMRfinance.yahoo.com - April 25 at 11:49 PMBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55marketbeat.com - April 24 at 2:24 PMLyme Disease Diagnostic Market Research Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030finance.yahoo.com - April 21 at 8:37 PMBio-Rad’s Chief Operating Officer Andrew Last to Retirebusinesswire.com - April 10 at 5:51 PMBio-Rad Laboratories (NYSE:BIO.B) Shares Down 1.6% marketbeat.com - April 9 at 12:27 AMUnlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care Solutionsfinance.yahoo.com - April 1 at 11:26 PMGlobal Glucometer Market Projected to Reach $30.5 Billion by 2030, With a CAGR of 8.9%uk.finance.yahoo.com - April 1 at 1:25 PMBio-Rad launches validated antibodies for rare cell and circulating tumor cell enumerationmsn.com - March 26 at 10:11 AMBIO Apr 2024 350.000 putfinance.yahoo.com - March 17 at 11:11 PMBIO Apr 2024 330.000 callfinance.yahoo.com - March 16 at 10:13 AMInsightAce Analytics Pvt. Ltd.: Combo IVD Market worth $920.9 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.finanznachrichten.de - March 14 at 10:33 AMBio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy productionmsn.com - February 27 at 1:24 PMBio-Rad Laboratories is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - February 14 at 3:39 PMRecombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets™.finance.yahoo.com - February 6 at 2:25 AMMeta's fake videos should be labelled, says boardnz.finance.yahoo.com - February 5 at 6:24 AMRBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)markets.businessinsider.com - January 27 at 12:11 AMBe Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of ...businesswire.com - December 10 at 3:47 PMBio-Rad (BIO) Hurt by Macroeconomic Woes, Margin Pressuremsn.com - November 14 at 10:29 AMBio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimatesfinance.yahoo.com - October 26 at 7:56 PMBio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spendingreuters.com - October 26 at 7:56 PMBio-Rad Laboratories Inc. Class Bthestreet.com - September 13 at 6:08 PMBio-Rad and QIAGEN announce patent settlement and cross-licensing agreementtechnews.tmcnet.com - July 26 at 5:04 PMBio-Rad Laboratories (BIO) Dips More Than Broader Markets: What You Should Knowmsn.com - June 16 at 8:43 PMThe Latest Analyst Ratings for Bio-Rad Laboratoriesmarkets.businessinsider.com - June 16 at 3:42 PMBio-Rad Laboratories (BIO) Outpaces Stock Market Gains: What You Should Knowmsn.com - June 9 at 7:40 PMDeath Cross Looms Over Bio-Rad Laboratories Investorsmsn.com - May 24 at 1:14 PMCredit Suisse Maintains Bio-Rad Laboratories Inc. - (BIO) Outperform Recommendationmsn.com - May 5 at 8:39 PMBio-Rad’s stock leads the S&P 500 decliners, as they suffer the biggest selloff in 36 years after disappointing results.msn.com - May 5 at 3:38 PMBio-Rad Laboratories (BIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Releasemsn.com - April 27 at 1:59 PMNona Biosciences Enters into Collaboration Agreement with ExeVir Biomarkets.businessinsider.com - April 6 at 1:04 AM2023-2029 Global Hepatitis B Testing Market Business Explorationmarketwatch.com - March 22 at 8:53 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Zimmer Biomet Holdings (ZBH)markets.businessinsider.com - March 9 at 10:18 AMBio-Rad (BIO) Global Expansion Strong, FX Woe Dents Growthmsn.com - March 9 at 10:18 AMBio-Rad Laboratories (BIO) Upgraded From Hold to Buythestreet.com - January 15 at 8:24 PMGT Molecular Releases Respiratory Panels and Poliovirus Typing Assays for Leading PCR Platformsmarkets.businessinsider.com - December 20 at 8:15 PMAnimal health diagnostics market: Growth opportunities led by Bio Rad Laboratories Inc. and Bio X Diagnostics SA - Technavioyahoo.com - December 8 at 3:20 AMBio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Downmsn.com - October 28 at 9:19 PMBio-Rad Laboratories (BIO) Surpasses Q3 Earnings Estimatesmsn.com - October 27 at 7:53 PMBio-Rad Laboratories, Qiagen Mull Merger Of Equalsmsn.com - October 11 at 8:34 AMEast Bay life sciences company reportedly in talks with Qiagen in $10 billion dealbizjournals.com - October 10 at 5:31 PMThe Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast periodbenzinga.com - September 29 at 4:33 PMIs Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?finance.yahoo.com - June 20 at 7:02 AMBio-Rad Laboratories Inc. Class Athestreet.com - June 13 at 3:14 AMThe 4.8% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 140%finance.yahoo.com - May 28 at 10:15 AMWall Street Analysts Believe Bio-Rad (BIO) Could Rally 53%: Here's is How to Tradefinance.yahoo.com - May 25 at 12:04 PMWorldwide Mononucleosis Diagnostic Industry to 2027 - Rising Health Awareness and Knowledge Among Patients is Driving Growth - ResearchAndMarkets.comapnews.com - April 25 at 3:21 PMPolymerase Chain Reaction Market to Advance at CAGR of 6.4% During 2021–2028, Says TMRsg.finance.yahoo.com - April 17 at 1:05 PMEarnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Declinenasdaq.com - February 3 at 5:49 PMOutlook on the Cell Isolation Global Market to 2026 - by Technique, Cell Type, Product, Application, End-use and Region - ResearchAndMarkets.comuk.finance.yahoo.com - December 15 at 3:23 PMMetabolomics Global Market Report 2021: COVID-19 Growth and Change to 2030 - ResearchAndMarkets.comapnews.com - December 14 at 7:42 AM Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. BIO.B Media Mentions By Week BIO.B Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO.B News Sentiment▼0.660.33▲Average Medical News Sentiment BIO.B News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO.B Articles This Week▼30▲BIO.B Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BIO News Today TXG News Today RVTY News Today OLK News Today AVTR News Today WAT News Today ILMN News Today PEN News Today EHC News Today CERE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO.B) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
